/NUS

NUS Stock - Nu Skin Enterprises, Inc.

Q: What is the analyst price target for NUS?

Analyst price target information is not currently available for NUS.

Q: What is NUS's market cap?

Market capitalization information is not currently available for NUS.

Consumer Defensive|Household & Personal Products|NYSE

$10.27+0.20%

+$0.02 (+0.20%) • Dec 19

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

BUY

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

100

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+119.1%upside

Target: $22.50

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for NUS

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2020

FY2021

FY2022

FY2023

FY2024

← Swipe to see more →

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta0.99

52W High$14.62

52W Low$5.32

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2024	FY2023	FY2022	FY2021	FY2020
Revenue	$1.73B	$1.97B	$2.23B	$2.70B	$2.58B
Gross Profit	$1.18B	$1.36B	$1.59B	$2.02B	$1.92B
Gross Margin	68.2%	68.9%	71.7%	75.0%	74.5%
Operating Income	$-151,585,000	$48.27M	$110.85M	$233.99M	$257.56M
Net Income	$-146,594,000	$8.60M	$104.78M	$147.27M	$191.35M
Net Margin	-8.5%	0.4%	4.7%	5.5%	7.4%
EPS	$-2.95	$0.17	$2.10	$2.93	$3.66

Company Overview

Nu Skin Enterprises, Inc. develops and distributes beauty and wellness products worldwide. It provides skin care systems, including ageLOC Spa systems, ageLOC Transformation anti-aging skin care systems, and ageLOC LumiSpa skin treatment and cleansing devices; and ageLOC Boost, as well as a range of other cosmetic and personal care products. The company also offers ageLOC Youth nutritional supplements, ageLOC TR90 weight management and body shaping systems, LifePak nutritional supplements, ageLOC Meta nutritional supplements, and Beauty Focus Collagen+ skin care supplements, as well as other weight management products. In addition, it is involved in the research and product development of skin care products and nutritional supplements. Further, the company operates retail stores and service centers in Mainland China. It sells its products under the Nu Skin, Pharmanex, and ageLOC brands. The company promotes and sells its products directly, as well as through distributors and Website. Nu Skin Enterprises, Inc. was founded in 1984 and is headquartered in Provo, Utah.

Visit Website

Rating Distribution

Strong Buy

Buy / Outperform

Hold / Neutral

100%

Sell / Underperform

Analyst Consensus🔴 Bearish

0 Bullish1 Neutral/Bearish

Price Targets

$39

Average Target

↑ 279.7% Upside

Now

$39

Low

$39

Average

$39

High

Based on 1 analyst

Recent Analyst Actions

Date	Firm	Action	Rating	Price Target
January 31st 2023	Jefferies	Downgrade	Hold	$39← $43

Earnings History & Surprises

NUS

Beat Rate

83%

Last 18 quarters

Avg Surprise

+21.3%

EPS vs Estimate

Beats / Misses

15/3

Last 12 quarters

Latest EPS

$0.34

Q4 2025

EPS Surprise History

Q1 24

+27.6%

$0.37vs$0.29

Q2 24

+80.0%

$0.09vs$0.05

Q3 24

+16.7%

$0.21vs$0.18

Q4 24

-15.0%

$0.17vs$0.20

Q1 25

+58.3%

$0.38vs$0.24

Q2 25

+53.3%

$0.23vs$0.15

Q3 25

+72.0%

$0.43vs$0.25

Q4 25

+13.3%

$0.34vs$0.30

Beat Estimate

Missed Estimate

Quarterly EPS Details

Period	Report Date	Estimated EPS	Actual EPS	Surprise	Result
Q2 2026	May 6, 2026	—	—	—	—
Q1 2026	Feb 12, 2026	$0.30	—	—	—
Q4 2025	Nov 6, 2025	$0.30	$0.34	+13.3%	✓ BEAT
Q3 2025	Aug 7, 2025	$0.25	$0.43	+72.0%	✓ BEAT
Q2 2025	May 8, 2025	$0.15	$0.23	+53.3%	✓ BEAT
Q1 2025	Feb 13, 2025	$0.24	$0.38	+58.3%	✓ BEAT
Q4 2024	Nov 7, 2024	$0.20	$0.17	-15.0%	✗ MISS
Q3 2024	Aug 8, 2024	$0.18	$0.21	+16.7%	✓ BEAT
Q2 2024	May 8, 2024	$0.05	$0.09	+80.0%	✓ BEAT
Q1 2024	Feb 14, 2024	$0.29	$0.37	+27.6%	✓ BEAT
Q4 2023	Nov 1, 2023	$0.64	$0.56	-12.5%	✗ MISS
Q3 2023	Aug 1, 2023	$0.53	$0.54	+1.9%	✓ BEAT
Q2 2023	May 3, 2023	$0.33	$0.37	+12.1%	✓ BEAT
Q1 2023	Feb 15, 2023	$0.53	$0.89	+67.9%	✓ BEAT
Q4 2022	Nov 2, 2022	$0.78	$0.47	-39.7%	✗ MISS
Q3 2022	Aug 4, 2022	$0.75	$0.77	+2.7%	✓ BEAT
Q2 2022	May 4, 2022	$0.72	$0.76	+5.6%	✓ BEAT
Q1 2022	Feb 16, 2022	$0.95	$1.11	+16.8%	✓ BEAT
Q4 2021	Nov 3, 2021	$0.86	$0.97	+12.8%	✓ BEAT
Q3 2021	Aug 4, 2021	$1.05	$1.15	+9.5%	✓ BEAT

Frequently Asked Questions about NUS

What is NUS's current stock price?

Nu Skin Enterprises, Inc. (NUS) is currently trading at $10.27 per share. The stock has moved +0.20% today.

What is the analyst price target for NUS?

The average analyst price target for NUS is $22.50, based on 1 analyst.

What sector is Nu Skin Enterprises, Inc. in?

Nu Skin Enterprises, Inc. operates in the Consumer Defensive sector, specifically within the Household & Personal Products industry. The company is traded on the NYSE exchange.

What is NUS's market cap?

Nu Skin Enterprises, Inc. has a market capitalization of $0.51 billion, making it a small-cap company.

Does NUS pay dividends?

No, Nu Skin Enterprises, Inc. does not currently pay a dividend to shareholders.